YAMADA Consulting Group  CO.,LTD. Logo

YAMADA Consulting Group CO.,LTD.

Japanese consulting firm offering global M&A, strategy, and financial advisory services.

4792 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
千代田区丸の内1−8−1丸の内トラストタワーN館
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

YAMADA Consulting Group is one of Japan's largest independent consulting firms, providing a comprehensive range of management and financial advisory services. The company specializes in business consulting for small and medium-sized enterprises but also serves multinational corporations and government agencies. Core services include strategy development based on primary information, investment research, and M&A transaction support. With a direct presence in Asia, the Middle East, and the USA, and through strategic partnerships such as Clairfield International, YAMADA offers seamless cross-border M&A advisory and global consulting solutions. The firm's subsidiary, Yamada Consulting & Spire, acts as a regional headquarters to capitalize on opportunities in the Asian market.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for YAMADA Consulting Group CO.,LTD. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-24 10:02
Regulatory News Service
臨時報告書
Japanese 27.5 KB
2025-06-20 09:53
Regulatory News Service
内部統制報告書-第36期(2024/04/01-2025/03/31)
Japanese 23.2 KB
2025-06-20 09:53
Regulatory News Service
確認書
Japanese 8.6 KB
2025-06-20 09:52
Annual Report
有価証券報告書-第36期(2024/04/01-2025/03/31)
Japanese 1.1 MB
2025-05-27 09:24
Regulatory News Service
臨時報告書
Japanese 19.6 KB
2025-01-10 03:36
Regulatory News Service
臨時報告書
Japanese 20.0 KB
2024-11-13 08:26
Interim Report
半期報告書-第36期(2024/04/01-2025/03/31)
Japanese 214.7 KB
2024-11-13 08:26
Regulatory News Service
確認書
Japanese 8.5 KB
2024-06-28 07:21
Regulatory News Service
臨時報告書
Japanese 23.7 KB
2024-06-28 06:18
Regulatory News Service
内部統制報告書-第35期(2023/04/01-2024/03/31)
Japanese 22.8 KB
2024-06-28 06:17
Regulatory News Service
確認書
Japanese 8.6 KB
2024-06-28 06:15
Annual Report
有価証券報告書-第35期(2023/04/01-2024/03/31)
Japanese 1.0 MB
2024-02-13 06:38
Regulatory News Service
確認書
Japanese 8.5 KB
2024-02-13 06:37
Quarterly Report
四半期報告書-第35期第3四半期(2023/10/01-2023/12/31)
Japanese 197.9 KB
2023-11-13 08:23
Regulatory News Service
確認書
Japanese 8.5 KB

Automate Your Workflow. Get a real-time feed of all YAMADA Consulting Group CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for YAMADA Consulting Group CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Developing novel cancer immunotherapies, including peptide vaccines and iPS-NKT cell therapies.
Japan 4594
Brilliant Future AB Logo
A data-driven survey platform to measure and improve employee & customer experiences.
Sweden BRILL
b-style holdings,Inc. Logo
Offers flexible staffing for homemakers and specialized recruitment for skilled professionals.
Japan 302A
BTS Group Logo
Helps organizations execute strategy via experiential learning for leadership and sales teams.
Sweden BTS
B.U Technology Logo
Commercializes university research via IP management, licensing, and new venture creation.
South Korea 230980
Advancing high-grade copper and precious metal projects from discovery to production.
Canada N/A
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland CTX
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan 6070
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan 4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.